As part of the London Proteomics Discussion Group webinar series: "SARS-CoV-2: What role can proteomics play?" Dr Münch presented his work on changes in response to SARS-CoV-2 infection, highlighting potential therapies. This was presented on 3rd Aptil 2020 to a global audience.
Register for part two of the series here.
SARS-CoV-2 Infected Host Cell Proteomics Reveal Potential Therapy Targets
Like what you just watched? You can find similar content on the communities below.Analysis & Separations Cell Science Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE